Cargando…
Sickle cell disease is a global prototype for integrative research and healthcare
Differences in health outcomes and treatment responses within and between global populations have been well documented. There is growing recognition of the need to move beyond simple inventories and descriptions of these differences and our linear explanations for them, and gain a better understandi...
Autores principales: | Royal, Charmaine D. M., Babyak, Michael, Shah, Nirmish, Srivatsa, Shantanu, Stewart, Kearsley A., Tanabe, Paula, Wonkam, Ambroise, Asnani, Monika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744540/ https://www.ncbi.nlm.nih.gov/pubmed/36618444 http://dx.doi.org/10.1002/ggn2.10037 |
Ejemplares similares
-
The future of sickle cell disease therapeutics rests in genomics
por: Wonkam, Ambroise
Publicado: (2023) -
Evolutionary history of sickle-cell mutation: implications for global genetic medicine
por: Esoh, Kevin, et al.
Publicado: (2021) -
Sickle cell disease and H3Africa: enhancing genomic research on cardiovascular diseases in African patients
por: Wonkam, Ambroise, et al.
Publicado: (2015) -
Implementation science research for the scale-up of evidence-based interventions for sickle cell disease in africa: a commentary
por: Gyamfi, Joyce, et al.
Publicado: (2021) -
Sickle cell disease in Africa: an urgent need for longitudinal cohort studies
por: Wonkam, Ambroise, et al.
Publicado: (2019)